NovaBay Pharmaceuticals, Inc. (NBY)

-0.004 (-0.54%)
At close: May 31, 2023, 3:59 PM
+0.002 (0.37%)
After-hours: May 31, 2023, 8:00 PM EDT

Total Valuation

NBY has a market cap or net worth of $1.77 million. The enterprise value is -$36,564.

Market Cap 1.77M
Enterprise Value -36,564

Important Dates

The last earnings date was Thursday, May 11, 2023, after market close.

Earnings Date May 11, 2023
Ex-Dividend Date n/a

Share Statistics

NBY has 2.73 million shares outstanding. The number of shares has increased by 42.21% in one year.

Shares Outstanding 2.73M
Shares Change (YoY) +42.21%
Shares Change (QoQ) +7.30%
Owned by Insiders (%) 14.60%
Owned by Institutions (%) 8.92%
Float 2.31M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.13
Forward PS 0.09
PB Ratio 0.19
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.22.

Current Ratio 2.24
Quick Ratio 1.26
Debt / Equity 0.22
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -146.10% and return on invested capital (ROIC) is -185.30%.

Return on Equity (ROE) -146.10%
Return on Assets (ROA) -95.20%
Return on Capital (ROIC) -185.30%
Revenue Per Employee $470,276
Profits Per Employee -$617,000
Employee Count 29
Asset Turnover 0.73
Inventory Turnover 1.59


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -91.10% in the last 52 weeks. The beta is 2.73, so NBY's price volatility has been higher than the market average.

Beta (1Y) 2.73
52-Week Price Change -91.10%
50-Day Moving Average 1.25
200-Day Moving Average 2.85
Average Volume (30 Days) 443,980

Short Selling Information

The latest short interest is 148,455, so 5.44% of the outstanding shares have been sold short.

Short Interest 148,455
Short Previous Month 87,016
Short % of Shares Out 5.44%
Short % of Float 6.41%
Short Ratio (days to cover) 0.42

Income Statement

In the last 12 months, NBY had revenue of $13.64 million and -$17.89 million in losses. Loss per share was -$10.60.

Revenue 13.64M
Gross Profit 7.62M
Operating Income -13.77M
Pretax Income -12.24M
Net Income -17.89M
EBITDA -11.82M
EBIT -12.24M
Loss Per Share -$10.60
Full Income Statement

Balance Sheet

The company has $3.75 million in cash and $1.98 million in debt, giving a net cash position of $1.77 million or $0.65 per share.

Cash & Cash Equivalents 3.75M
Total Debt 1.98M
Net Cash 1.77M
Net Cash Per Share $0.65
Equity / Book Value 8.89M
Book Value Per Share 3.26
Working Capital 5.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.21 million and capital expenditures -$101,000, giving a free cash flow of -$6.31 million.

Operating Cash Flow -6.21M
Capital Expenditures -101,000
Free Cash Flow -6.31M
FCF Per Share -$3.10
Full Cash Flow Statement


Gross margin is 55.84%, with operating and profit margins of -100.96% and -131.20%.

Gross Margin 55.84%
Operating Margin -100.96%
Pretax Margin -89.72%
Profit Margin -131.20%
EBITDA Margin -86.69%
EBIT Margin -89.72%
FCF Margin -46.26%

Dividends & Yields

NBY does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -1,033.42%
FCF Yield -364.38%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -42.21%
Shareholder Yield -42.21%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on November 16, 2022. It was a reverse split with a ratio of 1:35.

Last Split Date Nov 16, 2022
Split Type Reverse
Split Ratio 1:35